| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/31/2023 | 16.96% | Raymond James | $145 → $150 | Maintains | Strong Buy |
| 01/17/2023 | 5.26% | Oppenheimer | $138 → $135 | Maintains | Outperform |
| 11/03/2022 | 5.26% | UBS | → $135 | Downgrades | Buy → Neutral |
| 09/02/2022 | 13.06% | Stifel | $127 → $145 | Maintains | Buy |
| 08/04/2022 | -3.31% | BMO Capital | $104 → $124 | Maintains | Outperform |
| 08/04/2022 | 13.06% | Raymond James | $135 → $145 | Maintains | Strong Buy |
| 08/04/2022 | 9.16% | Needham | $125 → $140 | Maintains | Buy |
| 05/06/2022 | 5.26% | Raymond James | $130 → $135 | Maintains | Strong Buy |
| 04/22/2022 | 1.36% | Raymond James | $125 → $130 | Maintains | Strong Buy |
| 04/05/2022 | -6.43% | Goldman Sachs | $95 → $120 | Upgrades | Sell → Neutral |
| 03/30/2022 | 1.36% | DA Davidson | → $130 | Initiates Coverage On | → Buy |
| 01/10/2022 | -2.53% | Raymond James | $120 → $125 | Upgrades | Outperform → Strong Buy |
| 11/04/2021 | -6.43% | Raymond James | $110 → $120 | Maintains | Outperform |
| 11/04/2021 | -2.53% | Needham | $120 → $125 | Maintains | Buy |
| 09/21/2021 | -2.53% | CJS Securities | → $125 | Upgrades | Market Perform → Market Outperform |
| 08/05/2021 | -14.23% | Raymond James | $107 → $110 | Maintains | Outperform |
| 08/05/2021 | -6.43% | Needham | $110 → $120 | Maintains | Buy |
| 05/06/2021 | -16.57% | Raymond James | $100 → $107 | Maintains | Outperform |
| 05/06/2021 | -14.23% | Needham | $107 → $110 | Maintains | Buy |
| 03/09/2021 | -16.57% | Needham | $104 → $107 | Maintains | Buy |
| 02/25/2021 | -25.93% | Oppenheimer | $90 → $95 | Maintains | Outperformer |
| 02/25/2021 | -22.03% | Raymond James | $85 → $100 | Maintains | Outperform |
| 02/25/2021 | -18.91% | Needham | $91 → $104 | Maintains | Buy |
| 01/21/2021 | -25.15% | Berenberg | → $96 | Upgrades | Hold → Buy |
| 11/10/2020 | -33.72% | Raymond James | → $85 | Upgrades | Market Perform → Outperform |
| 11/05/2020 | -37.62% | UBS | $68 → $80 | Upgrades | Neutral → Buy |
| 11/05/2020 | -41.52% | Needham | $72 → $75 | Maintains | Buy |
| 08/06/2020 | -45.42% | BMO Capital | $63 → $70 | Maintains | Outperform |
| 08/06/2020 | -37.62% | Stifel | $75 → $80 | Maintains | Buy |
| 06/19/2020 | -45.42% | Needham | $67 → $70 | Maintains | Buy |
| 04/30/2020 | -47.76% | Needham | $70 → $67 | Maintains | Buy |
| 04/24/2020 | -41.52% | Stifel | $80 → $75 | Maintains | Buy |
| 04/16/2020 | -45.42% | Needham | $80 → $70 | Maintains | Buy |
| 04/02/2020 | -50.88% | BMO Capital | $93 → $63 | Maintains | Outperform |
| 03/27/2020 | -37.62% | Needham | $92 → $80 | Maintains | Buy |
| 03/20/2020 | -37.62% | Stifel | $96 → $80 | Maintains | Buy |
| 02/28/2020 | -30.6% | Goldman Sachs | → $89 | Assumes | → Neutral |
| 12/06/2019 | -17.35% | Baird | $95 → $106 | Maintains | Outperform |
| 11/22/2019 | -41.52% | Jefferies | → $75 | Initiates Coverage On | → Underperform |
| 10/31/2019 | -25.93% | Baird | $85 → $95 | Maintains | Outperform |
| 08/23/2019 | -32.94% | Needham | → $86 | Reinstates | → Buy |
| 08/01/2019 | -33.72% | Baird | $82 → $85 | Maintains | Outperform |
| 08/01/2019 | — | Oppenheimer | Upgrades | Perform → Outperform | |
| 04/04/2019 | -43.08% | UBS | $70 → $73 | Maintains | Neutral |
| 02/28/2019 | -41.52% | BMO Capital | $60 → $75 | Maintains | Outperform |
| 11/01/2018 | -40.74% | BMO Capital | $78 → $76 | Maintains | Outperform |
| 09/25/2018 | -37.62% | Stifel | $70 → $80 | Maintains | Buy |
| 08/02/2018 | -44.64% | BMO Capital | $65 → $71 | Maintains | Outperform |
| 08/02/2018 | -45.42% | Stifel | $65 → $70 | Maintains | Buy |
| 05/03/2018 | — | Baird | Upgrades | Neutral → Outperform | |
| 05/03/2018 | — | Canaccord Genuity | Upgrades | Hold → Buy | |
| 03/15/2018 | -61.79% | UBS | → $49 | Initiates Coverage On | → Sell |
| 03/01/2018 | -57.89% | Canaccord Genuity | $57 → $54 | Maintains | Hold |
| 03/01/2018 | -53.22% | BMO Capital | $61 → $60 | Maintains | Outperform |
| 03/01/2018 | -49.32% | Stifel | $70 → $65 | Maintains | Buy |
| 03/01/2018 | — | Oppenheimer | Downgrades | Outperform → Perform |
What is the target price for Clean Harbors (CLH)?
The latest price target for Clean Harbors (NYSE: CLH) was reported by Raymond James on January 31, 2023. The analyst firm set a price target for $150.00 expecting CLH to rise to within 12 months (a possible 16.96% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Clean Harbors (CLH)?
The latest analyst rating for Clean Harbors (NYSE: CLH) was provided by Raymond James, and Clean Harbors maintained their strong buy rating.
When is the next analyst rating going to be posted or updated for Clean Harbors (CLH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Clean Harbors, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Clean Harbors was filed on January 31, 2023 so you should expect the next rating to be made available sometime around January 31, 2024.
Is the Analyst Rating Clean Harbors (CLH) correct?
While ratings are subjective and will change, the latest Clean Harbors (CLH) rating was a maintained with a price target of $145.00 to $150.00. The current price Clean Harbors (CLH) is trading at is $128.25, which is out of the analyst's predicted range.